Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial-Reference-Cited by-同舟云学术

Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial

Published:2018-03-28 Issue:7 Volume:113 Page:1264-1273
ISSN:0965-2140
Container-title:Addiction
language:en
Short-container-title:Addiction

Author:

Bansback Nick¹²^ORCID,Guh Daphne¹,Oviedo-Joekes Eugenia¹²,Brissette Suzanne³,Harrison Scott⁴,Janmohamed Amin¹,Krausz Michael¹⁵,MacDonald Scott⁴,Marsh David C.⁶,Schechter Martin T.¹²,Anis Aslam H.¹²

Affiliation:

1. Centre for Health Evaluation and Outcome Sciences; Providence Health Care, St Paul's Hospital; Vancouver British Columbia Canada

2. School of Population and Public Health, Faculty of Medicine; University of British Columbia; Vancouver Canada

3. Centre de Recherche du Centre Hospitalier de l’Université de Montréal; Montréal Québec Canada

4. Providence Crosstown Clinic; Providence Health Care; Vancouver British Columbia Canada

5. Department of Psychiatry; University of British Columbia; Vancouver Canada

6. Northern Ontario School of Medicine; Sudbury Ontario Canada

Funder

Canadian Institutes of Health Research

Providence Health Care

InnerChange Foundation

Providence Health Care Research Institute

St. Paul's Foundation

Vancouver Coastal Health Research Institute

Publisher

Wiley

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/add.14171/fullpdf

Reference45 articles.

1. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence;Mattick;Cochrane Database Syst Rev,2014

2. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence;Mattick;Cochrane Database Syst Rev,2009

3. Heroin maintenance for chronic heroin-dependent individuals;Ferri;Cochrane Database Syst Rev,2010

4. Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction;Strang;Br J Psychiatry,2015

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analyzing quality of life among people with opioid use disorder from the National Institute on Drug Abuse Data Share initiative: implications for decision making;Quality of Life Research;2024-08-08

2. Client preferences for the design and delivery of injectable opioid agonist treatment services: Results from a best–worst scaling task;Addiction;2024-07-25

3. Informing evidence-based medicine for opioid use disorder using pharmacoeconomic studies;Expert Review of Pharmacoeconomics & Outcomes Research;2024-05-09

4. Quality of Life Assessment in Danish Heroin Assisted Treatment Patients: Validity of the SF-36 Survey;Journal of Psychosocial Rehabilitation and Mental Health;2024-04-11

5. Co-located Heroin Assisted Treatment within primary care: A preliminary analysis of the implications for healthcare access, cost, and treatment delivery in the UK;International Journal of Drug Policy;2024-04